skip to content

What's new!

23 July, 2007
License agreement reached to provide RNAi research products.


On July 9, 2007, Hayashi Kasei finalized a license agreement with Alnylam Pharmaceuticals to provide research products.
Below is the press release by Alnylam Pharmaceuticals.

http://phx.corporate-ir.net/phoenix.zhtml?c=148005&p=irol-newsArticle2&ID=1027947&highlight=
TPO PAGE
back to top